Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Inhibition of breast cancer progression by an antibody to a thrombospondin-1 receptor.

Inhibition of breast cancer progression by an antibody to a thrombospondin-1 receptor. Surgery. 1996 Aug; 120(2):449-54.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.